Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: A randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated

Y. M. Chen, R. P. Perng, Y. C. Lee, J. F. Shih, C. S. Lee, C. M. Tsai, J. Whang-Peng

Research output: Contribution to journal › Article › peer-review

55 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: A randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology